21/07/2010 | A Sydney-based oncologist has voiced caution when considering the effectiveness of epidermal growth factor receptor inhibiting drugs on some forms of bowel cancer at the Sydney Cancer Conference this week.
07/07/2010 | Australia’s national bowel cancer screening program has been shaped by financial and political constraints rather than medical evidence, researchers warn.
23/06/2010 | Celecoxib is associated with substantially fewer lower gastrointestinal adverse events than a non-selective NSAID in combination with a proton pump inhibitor, a large trial in patients with osteoarthritis or rheumatoid arthritis has suggested.
09/06/2010 | The addition of cetuximab to standard adjuvant chemotherapy with FOLFOX does not extend disease free survival or overall survival for patients with stage III colon cancer with wild-type KRAS, a phase III study finds.
09/06/2010 | Capecitabine and bevacizumab should be considered a first line therapy option for patients with metastatic colorectal cancer, say the Australasian Gastrointestinal Trials Group.
09/06/2010 | The cost of treating bowel cancer in Australia will reach $1 billion next year, a four-fold increase over the last decade, researchers say.
26/05/2010 | A study of patients presenting to their GPs with troublesome upper GI symptoms has found that GPs’ and gastroenterologists’ clinical diagnoses and the 12-item Reflux Diseases Questionnaire have similar accuracy, but a trial of esomeprazole therapy does little to clarify the situation.
12/05/2010 | Cases of non-cardia gastric cancer are increasing among Caucasian patients from their mid-20s and 30s, research suggests, despite a decline in all other age groups and races.
13/04/2010 | Pharmacists need guidelines on when to refer people presenting with lower bowel symptoms to their GP, Australian research shows.
13/04/2010 | The increasing use of laparoscopic surgery is allowing surgeons to consider whether it is worth leaving a 'normal' looking appendix in situ, but the answer appears to be 'no'.